Recombinant Human ADM Protein，His

ADM (Adrenomedullin) is a peptide involved in various physiological processes, including vasodilation, cardiac function, and regulation of blood pressure. Research on ADM and its derivatives has gained momentum due to its potential therapeutic applications, particularly in cardiovascular diseases, sepsis, and organ dysfunction. ADM exerts its effects through specific receptors, leading to the activation of intracellular signaling pathways that promote cell survival and mitigate inflammatory responses. The study of ADM’s role in these pathways has sparked interest in its use as a biomarker for disease severity and prognosis. Additionally, the exploration of ADM recombinants aims to enhance its stability and bioavailability, which could lead to more effective treatment modalities. Understanding the structure-function relationship of ADM and the impact of modifications on its activity is crucial for developing novel therapeutic approaches. Advances in genetic engineering and recombinant DNA technology facilitate the production of ADM proteins, allowing researchers to investigate their efficacy in vitro and in vivo. Overall, the ongoing research on ADM reconstitution not only contributes to a deeper understanding of its physiological roles but also paves the way for innovative interventions in various medical conditions.